352 related articles for article (PubMed ID: 26794845)
21. Semaphorin-plexin signalling genes associated with human breast tumourigenesis.
Gabrovska PN; Smith RA; Tiang T; Weinstein SR; Haupt LM; Griffiths LR
Gene; 2011 Dec; 489(2):63-9. PubMed ID: 21925246
[TBL] [Abstract][Full Text] [Related]
22. Structural basis of semaphorin-plexin cis interaction.
Rozbesky D; Verhagen MG; Karia D; Nagy GN; Alvarez L; Robinson RA; Harlos K; Padilla-Parra S; Pasterkamp RJ; Jones EY
EMBO J; 2020 Jul; 39(13):e102926. PubMed ID: 32500924
[TBL] [Abstract][Full Text] [Related]
23. A role for class 3 semaphorins in prostate cancer.
Blanc V; Nariculam J; Munson P; Freeman A; Klocker H; Masters J; Williamson M
Prostate; 2011 May; 71(6):649-58. PubMed ID: 20949546
[TBL] [Abstract][Full Text] [Related]
24. Glial and neuronal Semaphorin signaling instruct the development of a functional myotopic map for Drosophila walking.
Syed DS; Gowda SB; Reddy OV; Reichert H; VijayRaghavan K
Elife; 2016 Feb; 5():e11572. PubMed ID: 26926907
[TBL] [Abstract][Full Text] [Related]
25. Mical links semaphorins to F-actin disassembly.
Hung RJ; Yazdani U; Yoon J; Wu H; Yang T; Gupta N; Huang Z; van Berkel WJ; Terman JR
Nature; 2010 Feb; 463(7282):823-7. PubMed ID: 20148037
[TBL] [Abstract][Full Text] [Related]
26. Relation of immune semaphorin/plexin signaling to carcinogenesis.
Műzes G; Sipos F
Eur J Cancer Prev; 2014 Sep; 23(5):469-76. PubMed ID: 24922268
[TBL] [Abstract][Full Text] [Related]
27. Semaphorins as emerging clinical biomarkers and therapeutic targets in cancer.
Mastrantonio R; You H; Tamagnone L
Theranostics; 2021; 11(7):3262-3277. PubMed ID: 33537086
[TBL] [Abstract][Full Text] [Related]
28. More than nervous: the emerging roles of plexins.
Perälä N; Sariola H; Immonen T
Differentiation; 2012 Jan; 83(1):77-91. PubMed ID: 22099179
[TBL] [Abstract][Full Text] [Related]
29. Plexin structures are coming: opportunities for multilevel investigations of semaphorin guidance receptors, their cell signaling mechanisms, and functions.
Hota PK; Buck M
Cell Mol Life Sci; 2012 Nov; 69(22):3765-805. PubMed ID: 22744749
[TBL] [Abstract][Full Text] [Related]
30. Semaphorins and Plexins in Kidney Disease.
Xia J; Worzfeld T
Nephron; 2016; 132(2):93-100. PubMed ID: 26844545
[TBL] [Abstract][Full Text] [Related]
31. Semaphorin signals on the road to cancer invasion and metastasis.
Rizzolio S; Tamagnone L
Cell Adh Migr; 2007; 1(2):62-8. PubMed ID: 19329883
[TBL] [Abstract][Full Text] [Related]
32. Semaphorin signaling in cancer cells and in cells of the tumor microenvironment--two sides of a coin.
Capparuccia L; Tamagnone L
J Cell Sci; 2009 Jun; 122(Pt 11):1723-36. PubMed ID: 19461072
[TBL] [Abstract][Full Text] [Related]
33. Semaphorins and plexins as therapeutic targets.
Worzfeld T; Offermanns S
Nat Rev Drug Discov; 2014 Aug; 13(8):603-21. PubMed ID: 25082288
[TBL] [Abstract][Full Text] [Related]
34. Plexins, semaphorins, and scatter factor receptors: a common root for cell guidance signals?
Artigiani S; Comoglio PM; Tamagnone L
IUBMB Life; 1999 Nov; 48(5):477-82. PubMed ID: 10637762
[TBL] [Abstract][Full Text] [Related]
35. Commissural axon navigation: Control of midline crossing in the vertebrate spinal cord by the semaphorin 3B signaling.
Pignata A; Ducuing H; Castellani V
Cell Adh Migr; 2016 Nov; 10(6):604-617. PubMed ID: 27532244
[TBL] [Abstract][Full Text] [Related]
36. p190 Rho-GTPase activating protein associates with plexins and it is required for semaphorin signalling.
Barberis D; Casazza A; Sordella R; Corso S; Artigiani S; Settleman J; Comoglio PM; Tamagnone L
J Cell Sci; 2005 Oct; 118(Pt 20):4689-700. PubMed ID: 16188938
[TBL] [Abstract][Full Text] [Related]
37. Class-3 Semaphorins and Their Receptors: Potent Multifunctional Modulators of Tumor Progression.
Toledano S; Nir-Zvi I; Engelman R; Kessler O; Neufeld G
Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30696103
[No Abstract] [Full Text] [Related]
38. Class 3 semaphorin signaling: the end of a dogma.
Potiron V; Roche J
Sci STKE; 2005 May; 2005(285):pe24. PubMed ID: 15914725
[TBL] [Abstract][Full Text] [Related]
39. Class 3 semaphorin in angiogenesis and lymphangiogenesis.
Bussolino F; Giraudo E; Serini G
Chem Immunol Allergy; 2014; 99():71-88. PubMed ID: 24217603
[TBL] [Abstract][Full Text] [Related]
40. The semaphorins and their receptors as modulators of tumor progression.
Neufeld G; Mumblat Y; Smolkin T; Toledano S; Nir-Zvi I; Ziv K; Kessler O
Drug Resist Updat; 2016 Nov; 29():1-12. PubMed ID: 27912840
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
